Navidea Biopharmaceuticals ROA 2006-2018 | NAVB
Current and historical return on assets (ROA) values for Navidea Biopharmaceuticals (NAVB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Navidea Biopharmaceuticals ROA for the three months ending December 31, 2018 was -150.07%.
| Navidea Biopharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-12-31 | $-0.02B | $0.01B | -148.84% |
| 2018-09-30 | $-0.02B | $0.01B | -119.30% |
| 2018-06-30 | $-0.01B | $0.01B | -78.87% |
| 2018-03-31 | $-0.02B | $0.02B | -77.27% |
| 2017-12-31 | $0.08B | $0.02B | 295.15% |
| 2017-09-30 | $0.08B | $0.02B | 323.40% |
| 2017-06-30 | $0.08B | $0.03B | 375.61% |
| 2017-03-31 | $0.08B | $0.03B | 461.54% |
| 2016-12-31 | $-0.02B | $0.01B | -136.36% |
| 2016-09-30 | $-0.01B | $0.01B | -119.15% |
| 2016-06-30 | $-0.02B | $0.01B | -166.04% |
| 2016-03-31 | $-0.03B | $0.01B | -151.52% |
| 2015-12-31 | $-0.03B | $0.02B | -172.31% |
| 2015-09-30 | $-0.03B | $0.02B | -206.45% |
| 2015-06-30 | $-0.03B | $0.02B | -196.83% |
| 2015-03-31 | $-0.03B | $0.01B | -190.77% |
| 2014-12-31 | $-0.04B | $0.01B | -165.52% |
| 2014-09-30 | $-0.04B | $0.02B | -149.57% |
| 2014-06-30 | $-0.05B | $0.02B | -127.89% |
| 2014-03-31 | $-0.05B | $0.03B | -122.08% |
| 2013-12-31 | $-0.04B | $0.04B | -124.44% |
| 2013-09-30 | $-0.04B | $0.05B | -130.84% |
| 2013-06-30 | $-0.03B | $0.03B | -185.92% |
| 2013-03-31 | $-0.03B | $0.01B | -193.33% |
| 2012-12-31 | $-0.03B | $0.01B | -163.38% |
| 2012-09-30 | $-0.03B | $0.01B | -133.33% |
| 2012-06-30 | $-0.00B | $0.02B | -3.67% |
| 2012-03-31 | $0.00B | $0.03B | 11.88% |
| 2011-12-31 | $0.01B | $0.03B | 26.67% |
| 2011-09-30 | $0.01B | $0.03B | 68.57% |
| 2011-06-30 | $-0.01B | $0.01B | -90.91% |
| 2011-03-31 | $-0.06B | $0.01B | -590.00% |
| 2010-12-31 | $-0.06B | $0.01B | -662.86% |
| 2010-09-30 | $-0.06B | $0.01B | -678.79% |
| 2010-06-30 | $-0.08B | $0.01B | -902.86% |
| 2010-03-31 | $-0.04B | $0.01B | -491.43% |
| 2009-12-31 | $-0.04B | $0.01B | -445.71% |
| 2009-09-30 | $-0.04B | $0.01B | -444.44% |
| 2009-06-30 | $-0.02B | $0.01B | -200.00% |
| 2009-03-31 | $-0.00B | $0.01B | -35.29% |
| 2008-12-31 | $-0.01B | $0.01B | -64.52% |
| 2008-09-30 | $-0.01B | $0.01B | -85.71% |
| 2008-06-30 | $-0.01B | $0.01B | -74.07% |
| 2008-03-31 | $-0.01B | $0.01B | -80.00% |
| 2007-12-31 | $-0.01B | $0.01B | -76.92% |
| 2007-09-30 | $-0.00B | $0.01B | -59.26% |
| 2007-06-30 | $-0.01B | $0.01B | -68.97% |
| 2007-03-31 | $-0.01B | $0.01B | -60.61% |
| 2006-12-31 | $-0.01B | $0.01B | -54.05% |
| 2006-09-30 | $-0.01B | $0.01B | -48.78% |
| 2006-06-30 | $-0.00B | $0.01B | -35.56% |
| 2006-03-31 | $-0.00B | $0.01B | -32.65% |
| 2005-12-31 | $-0.00B | $0.01B | -30.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.031B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $103.378B | 23.30 |
| Intuitive Surgical (ISRG) | United States | $56.692B | 52.24 |
| Edwards Lifesciences (EW) | United States | $37.089B | 37.93 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.075B | 16.48 |
| IDEXX Laboratories (IDXX) | United States | $19.067B | 51.90 |
| Teleflex (TFX) | United States | $12.648B | 27.70 |
| Hologic (HOLX) | United States | $12.527B | 18.94 |
| Varian Medical Systems (VAR) | United States | $11.844B | 29.58 |
| ABIOMED (ABMD) | United States | $11.764B | 77.66 |
| DexCom (DXCM) | United States | $10.616B | 402.10 |
| STERIS (STE) | United Kingdom | $10.425B | 26.79 |
| Masimo (MASI) | United States | $6.591B | 40.92 |
| Penumbra (PEN) | United States | $4.502B | 254.73 |
| Integra LifeSciences Holdings (IART) | United States | $4.416B | 21.39 |
| Globus Medical (GMED) | United States | $4.410B | 26.77 |
| Wright Medical Group (WMGI) | Netherlands | $3.555B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $3.292B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.208B | 19.78 |
| Cantel Medical (CMD) | United States | $2.683B | 26.68 |
| Glaukos (GKOS) | United States | $2.563B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.324B | 18.90 |
| Nevro (NVRO) | United States | $1.963B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.959B | 21.28 |
| Inogen (INGN) | United States | $1.729B | 34.29 |
| OPKO Health (OPK) | United States | $1.442B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $1.104B | 0.00 |
| SILK RD MEDICAL (SILK) | United States | $1.058B | 0.00 |
| CryoLife (CRY) | United States | $1.037B | 111.80 |
| Accelerate Diagnostics (AXDX) | United States | $1.028B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.016B | 27.63 |
| Luminex (LMNX) | United States | $0.985B | 44.67 |
| Veracyte (VCYT) | United States | $0.946B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.918B | 174.36 |
| Intersect ENT (XENT) | United States | $0.905B | 0.00 |
| Fluidigm (FLDM) | United States | $0.882B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.853B | 34.88 |
| Shockwave Medical (SWAV) | United States | $0.852B | 0.00 |
| Natus Medical (BABY) | United States | $0.813B | 16.86 |
| AxoGen (AXGN) | United States | $0.786B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.747B | 26.05 |
| ViewRay (VRAY) | United States | $0.685B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.529B | 0.00 |
| TransEnterix (TRXC) | United States | $0.447B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.431B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.422B | 44.06 |
| GenMark Diagnostics (GNMK) | United States | $0.399B | 0.00 |
| Si-Bone (SIBN) | United States | $0.393B | 0.00 |
| Accuray (ARAY) | United States | $0.366B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.362B | 44.73 |
| Pulse Biosciences (PLSE) | United States | $0.321B | 0.00 |
| IRadimed (IRMD) | United States | $0.294B | 62.12 |
| Neuronetics (STIM) | United States | $0.284B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.255B | 0.00 |
| Sientra (SIEN) | United States | $0.240B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.207B | 48.00 |
| SOLITON INC (SOLY) | $0.180B | 0.00 | |
| Nuvectra (NVTR) | United States | $0.174B | 0.00 |
| ConforMIS (CFMS) | United States | $0.160B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.146B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.131B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.129B | 0.00 |
| EDAP TMS (EDAP) | France | $0.129B | 444.00 |
| Second Sight Medical Products (EYES) | United States | $0.116B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 0.00 |
| Vermillion (VRML) | United States | $0.097B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.076B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.074B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.064B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.054B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.053B | 0.00 |
| Electromed (ELMD) | United States | $0.048B | 24.78 |
| Xtant Medical Holdings (XTNT) | United States | $0.039B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Neovasc (NVCN) | Canada | $0.031B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.027B | 0.00 |
| Avinger (AVGR) | United States | $0.026B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.026B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.024B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.023B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.020B | 64.00 |
| Dynatronics (DYNT) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 15.04 |
| OBALON THERPTCS (OBLN) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.010B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Micron Solutions (MICR) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| ALCON INC (ALC) | $0.000B | 0.00 |
